at our institution. We included patients who met the following criteria: 1) Diagnosis of a PFBT of any type, between birth and age 18 years, in patients who required surgery at least 1 year before the QOL assessment. 2) No chemotherapy or radiation therapy received within the last 6 months. 3) No evidence of progressive disease at the time of the assessment. 4) Aged 5 to under 19 years old at the time of the assessment. The outcome measures used in this study are only for those children 5 years or older and the concept of true QOL has been best studied in children who are at least of school age. 5) Parent or primary caregiver was able and willing to provide consent and able to read and write in English, since some of the outcome measures used in the study were only available in English.
Data Collection
Once consent was provided, we collected the following data. 1) Patient-related variables were extracted from the medical chart and included the following: age at assessment, age at first surgery, time since first tumor surgery (years), and time elapsed since last active treatment (chemotherapy or radiation) of tumors (years). 2) Treatment-related variables were extracted from the medical chart and included the following: length of initial hospitalization for PFBT treatment (days), tumor type (cerebellar pilocytic astrocytoma, medulloblastoma, ependymoma, brainstem astrocytoma, or other), postoperative mutism (yes/no), history of tumor recurrence (yes/no), use of chemotherapy (yes/no), use of craniospinal radiation therapy (yes/no), use of any radiation therapy (yes/no), need for permanent hydrocephalus treatment (yes/no), and preoperative and current ventricle size (using the validated frontal-occipital horn ratio 22, 27 ). 3) Socioeconomic data were determined by self-completed questionnaires given to the child's parents and included annual family income exceeding $80,000 (which is roughly the median income of all families in Canada: http://www.statcan. gc.ca/tables-tableaux/sum-som/l01/cst01/famil21a-eng. htm, accessed October 1, 2012) and whether either parent was a university graduate. The parents were also asked to complete the General Functioning Scale of the McMaster Family Assessment Device or the GF-FAD. 4, 25 This scale has proven reliability and validity and is based on a multidimensional model of family functioning that incorporates problem solving, communication, roles, affective responses, affective involvement, and behavior control. The scores on the GF-FAD range from 1 to 4, with an increase in the score indicating increased family pathology.
Outcome Measures
The current QOL of the patients was measured using the following outcome measures.
PedsQL Generic Core Scales. The PedsQL is a 23-item questionnaire that can be completed by the caregivers or by older children. 37, 38 It is a generic QOL measure that has been used in many different types of childhood illnesses, including brain tumors. 31 It has demonstrated good reliability and validity in different clinical settings. 35, 36 Each of the 23 items describes a specific problem, and the respondent is asked to rate this problem for the child on a 5-point scale (ranging from "never a problem" to "almost always a problem"). The responses are summarized to provide a total scale score (based on all 23 items) as well as separate physical health (8 items) and psychosocial health (15 items) summary scores, along with subscores of emotional, social, and school functioning (5 items each). The scores ranged from 0 (worst outcome) to 100 (best outcome). All caregivers completed the PedsQL, and children over 8 years of age with sufficient cognitive capacity also self-completed a PedsQL questionnaire.
HUI3. The HUI3 is a simple questionnaire that has taken various modified forms and has been used in different pediatric populations including those with brain tumors, and good reliability and validity have been demonstrated. 3, 13, 26, 34 The HUI3 assesses functioning in 7 domains (vision, hearing, dexterity, ambulation speech, emotion, cognition, and pain) and translates the individual health state into a utility score. 12 A utility score is an estimate of the relative preference for that state of health. For example, the utility score for "dead" is 0 and for "perfect health" is 1, and utility scores less than 0 indicate states described as "worse than dead." 7 
Statistical Analysis
Univariate analysis was used to determine an association between all potential predictor variables and the parent-completed PedsQL total scale score (primary-dependent variable). Continuous variables were tested with univariate regression and categorical variables with t-test or ANOVA. Those variables that appeared to be important (with a p value < 0.1) were entered together into a multivariate generalized linear model regression. This process was repeated using the PedsQL physical health score, the PedsQL psychosocial health score, and the HUI3 utility score as the dependent variable. Only the PedsQL parent-completed responses were used for analyses since the number of child-completed responses was too small. Our analyses were viewed as exploratory, and any variable with p < 0.05 in the multivariable model was considered to have an association of interest with the dependent variable. Analyses were performed using SPSS 17.0 statistical software (SPSS Inc.).
Results
Of 187 potentially eligible patients followed up at the Hospital for Sick Children, 90 (48%) were contacted, of whom a total of 62 (33%) participated between January 2007 and January 2010. Thirty-seven percent of all potentially eligible patients with medulloblastoma participated, 54% of those with ependymomas, 31% of those with cerebellar astrocytomas, and 30% of those with brainstem astrocytomas. The baseline characteristics, treatment-related factors, and socioeconomic characteristics of these patients are shown in Table 1 . Thirty-one children (50%) were younger than 5 years at tumor diagnosis and 10 (16.1%) were younger than 2 years old.
The QOL outcomes for the cohort are shown in Table 2 . The mean parent-completed PedsQL total scale score and HUI3 utility score for the different tumor types were the following, respectively: pilocytic astrocytoma (79.5 and 0.80), medulloblastoma (72.7 and 0.80), ependymoma (80.3 and 0.98), and brainstem astrocytoma (79.5 and 0.90). The differences in QOL outcome among the different tumor types were not statistically significant (all p > 0.3).
Regression Analyses
All variables listed in Table 1 were tested in univariate analyses for an association with the parent-completed PedsQL total scale score. Only the following variables were found to have a p < 0.1 in univariate analysis: preoperative ventricle size, current ventricle size, need for permanent hydrocephalus treatment, and family income greater than $80,000. These were entered into a multivariate model, the results of which are shown in Table  3 . Only family income greater than $80,000 (p = 0.007) and smaller current ventricle size (p = 0.013) were associated with a higher PedsQL total scale score. Results of the multivariate models for the PedsQL physical scale score, PedsQL psychosocial scale score, and HUI3 are shown in Tables 4, 5 , and 6, respectively. The need for permanent hydrocephalus treatment was the only variable associated with a lower PedsQL physical scale score (p = 0.03) and a lower HUI3 utility score (p = 0.008) ( Tables 4 and  6 ). The following were associated with a higher PedsQL psychosocial scale score: smaller current ventricle size (p = 0.01), better family functioning (assessed with the GF-FAD; p = 0.01), and family income greater than $80,000 (p = 0.03) ( Table 5 ).
Discussion
Posterior fossa brain tumors are the most common brain tumors in children. The QOL issues for survivors of pediatric PFBT are unique and relate to many potentially important factors, including physical, intellectual, and psychological concerns. Following surgical excision of a PFBT or as a result of the tumor growth itself, a child may be left with numerous physical deficits, including difficulty walking and running, balance and coordination problems, weakness, difficulty swallowing food, and visual and speech problems. As shown by Aarsen et al., even after treatment of a benign tumor, such as pilocytic astrocytoma, long-standing deficits such as apraxia, motor neglect, and speech dysarthria may persist. 1 The impact of any one of these deficits on the QOL of PFBT patients can be significant. Numerous studies have also highlighted the impact of chemotherapy and radiotherapy, especially cranial radiation, on long-term cognitive outcome in children. 2, 6, 14, 15, 29 These treatments especially affect nonverbal and processing skills. 2 Mulhern reported that cognition scores in children with medulloblastomas were significantly lower than those for other aspects of health, including mobility, emotion, and pain. 26 Finally, the prevalence of psychological distress, including depression, immaturity, and fearfulness, among long-term survivors of childhood brain tumors is quite high.
11 Many children also experience difficulties in social skills.
11 This is an area of QOL that has not been well studied.
One of the important findings of our study is that, on average, the overall QOL of children in our selected cohort was actually quite good. With mean PedsQL total scores of 77.2 (parent reported) and 81.7 (child reported), the results of our cohort compared favorably to those for healthy population samples whose PedsQL total scores have been reported to be 77.6 (parent reported) and 81.1 (child reported). 37 In addition, our results indicate a much better QOL for our PFBT survivor cohort than has been reported for many other disease conditions, such as cerebral palsy (51.3 parent reported and 66.9 child reported) 35 and children with a broad range of other cancers (69.7 parent reported and 72.2 child reported). 36 Previous work has suggested that the utility score for children with brain tumors is approximately 0.80 20 and for medulloblastoma survivors it is 0.94. 26 Those results are comparable to our cohort (with a HUI3 utility mean of 0.83 and median of 0.91), and they indicate a QOL that is substantially better than for children with hydrocephalus, 21 for example, and roughly similar to that of adolescents who were born with extremely low birth weight 33 and of the general population. 7 Although it is heartening that, on average, survivors of PFBT in this cohort have QOL outcomes within the range of the general population, it is also possible that, having survived the early treatment of a PFBT, this cohort holds a different view of outcome than the general population, which has not had to endure a life-threatening disease. That is, some of the responses of this cohort to the questions of QOL might be the result of a more optimistic interpretation. In addition, the summary statistics hide the fact that some of these children are clearly doing poorly by any measure, as can be seen from the range of these QOL outcome estimates. For example, 25% of our cohort had PedsQL total scores ≤ 64.1 and HUI3 utility scores ≤ 0.71 ( Table 2) .
The search for predictors of QOL outcome yielded 2 main groups: those relating to hydrocephalus (the need for permanent treatment and the size of ventricles) and those of a socioeconomic nature (family functioning and family income). Approximately 39% of the patients in our sample needed permanent hydrocephalus treatment, and it was not surprising that this was a negative predictor of outcome. Riva-Cambrin et al. found that children with PFBT who were at highest risk for needing permanent hydrocephalus treatment were < 2 years of age at surgery and had papilledema, moderate to severe hydrocephalus, presence of cerebral metastases, and presumed malignant pathologies (ependymoma or medulloblastoma). 32 Therefore, these likely represent children with severe disease presentation. In addition, the presence of a permanent hydrocephalus shunt can also result in detriments to QOL due to shunt complications, as has been observed in children with spina bifida. 16, 18 The association between decreased QOL outcome and larger ventricle size is not so easily explained. In children with hydrocephalus, some studies have observed an association between ventricle size and specific brain morphometric and cognitive changes, [8] [9] [10] but others have found no association with overall QOL outcome. 21, 23 It is possible that a large current ventricular size is a marker for long-standing hydrocephalus prior to presentation (and, thus, for ventriculomegaly that is less likely to fully normalize after treatment). Among socioeconomic factors, income > $80,000 (roughly in the upper half of all Canadian families) was associated with better outcome, whereas decreased family functioning on the GF-FAD scale was associated with poor QOL outcome. Previous studies in other populations have documented similar relationships of these socioeconomic variables with pediatric health outcome. 5, 17, 21 Caution needs to be exercised, however, in interpreting these factors, since Our study has important limitations. Our sample size, although one of the largest reported in a QOL study of PFBT, still limited the statistical power of our analyses, and so it is certainly possible that other important predictor variables were not identified in our study. Therefore, we cannot conclude that factors such as tumor type, radiation, and chemotherapy, for example, do not influence QOL. It is quite possible that these variables were false negatives resulting from the limited statistical power. Given its retrospective nature, much of the data collection relied on review of medical records, which will result in some degree of inaccuracy. For example, we found convincing evidence of cerebellar mutism in only 6.5% of our sample. This is almost certainly a gross underestimate of its true prevalence and a reflection of the limitations of retrospective data abstraction. Although our participation rate was reasonably high (69%), it is possible that those families who refused to participate had some characteristics that were systematically different from those of the study participants. If so, our results might not be truly representative of the overall outcome of all survivors of pediatric PFBT. In addition, by selecting only for the long-term survivors, we had biased our sample to those children who have done the very best following the treatment of their PFBT.
Conclusions
As a group, long-term survivors of pediatric PFBT appear to have QOL indicator scores that are similar to those of the general population, although a minority of these survivors experience poor outcomes. Although several confounding variables likely remain in this retrospective study, important associations with QOL include the presence of hydrocephalus and socioeconomic factors.
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